NCT05473156
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +25 more
- Locations
-
- AP Biosciences Inc. Taipei, Taiwan
Clinical trial condition
Head and Neck Squamous Cell Carcinoma (HNSCC)
Explore clinical trials studying Head and Neck Squamous Cell Carcinoma (HNSCC). Study availability and eligibility vary by location and protocol.
32 public trials
12 recruiting studies
Head and Neck Squamous Cell Carcinoma (HNSCC) trial results
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
- Locations
-
- Ospedale Oncologico "A. Businco" ARNAS BROTSU Cagliari, CAGLIARI, Italy
- Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-S. Marco Catania, CATANIA, Italy
- Azienda Ospedaliero-Universitaria Careggi Florence, FIRENZE, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori (INT) di Milano Milan, Milano, Italy
Not yet recruiting
[18F]-AraG PET Imaging in LA HNSCC
NCT07168785
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
- Locations
-
- Indiana University Indianapolis, Indiana, United States
Not yet recruiting
Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET
NCT06482307
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- University Medical Center Groningen Groningen, Netherlands
Not yet recruiting
Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT06714266
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
Not specified
NCT06530914
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
Not specified
Active, not recruiting
Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
NCT04080804
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Active, not recruiting
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
NCT05891171
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site Jacksonville, Florida, United States
- Research Site Lake City, Florida, United States
- Research Site Hinsdale, Illinois, United States
Active, not recruiting
Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma
NCT06673693
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +7 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Active, not recruiting
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +36 more
- Locations
-
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Cancer & Blood Specialty Clinic Los Alamitos, California, United States
- Moores Cancer Center at the UC San Diego Health San Diego, California, United States
- Yale University Cancer Center New Haven, Connecticut, United States